Subscribe

What are you looking for?

Main Menu

明報新聞網

和黃醫藥：啟動HMPL A830用於治療實體瘤的全球研究

Future Wealths
Future Wealths
28 9 月, 2026
One Min Read
2 Views
0 Comments
和黃醫藥(0013)今日宣布啟動HMPL A830用於治療不可切除的晚期或轉移性實體瘤的全球臨牀試驗的Ia期部分。首名患者已於2026年9月24日於中國接受首次給藥治療。

原文: https://finance.mingpao.com/fin/instantf/20260928/1790561988199/%E5%92%8C%E9%BB%83%E9%86%AB%E8%97%A5-%E5%95%9F%E5%8B%95hmpl-a830%E7%94%A8%E6%96%BC%E6%B2%BB%E7%99%82%E5%AF%A6%E9%AB%94%E7%98%A4%E7%9A%84%E5%85%A8%E7%90%83%E7%A0%94%E7%A9%B6%22%20target=%22blank

Last Update: 28 9 月, 2026

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept